CRISPR patent for Benson Hill Biosystems

Benson Hill Biosystems said the US Patent and Trademark Office granted it a patent related to CRISPR 3.0 Cms1 genome editing nucleases, further expanding the company’s suite of genomics tools to accelerate crop performance improvements.

“Benson Hill’s genome editing system Edit, powered by CropOS, enables companies across the agri-food value chain to tap natural genetic diversity as a powerful source of product differentiation to improve the health and sustainability of our food system,” said Benson Hill Biosystems.

Benson Hill Biosystems CEO Matthew Crisp said: “We’re excited about this first patent issuance relating to our CRISPR 3.0 nuclease portfolio, and we are excited to move forward with commercial and research applications of this technology.

“We will continue to pursue filings for a pipeline of technologies and applications that provide choice, clarity and confidence to our partners.”